text:
The time I need to prepare an order for shipping varies. For details, see individual items.
Buyers are responsible for any customs and import taxes that may apply. I'm not responsible for delays due to customs.
But please contact me if you have any problems with your order.
This Privacy Policy describes how and when I collect, use, and share information when you purchase an item from me, contact me, or otherwise use my services through Etsy.com or its related sites and services.
This Privacy Policy does not apply to the practices of third parties that I do not own or control, including Etsy or any third party services you access through Etsy. You can reference the Etsy Privacy Policy to learn more about its privacy practices.
Information I Collect
To fulfil your order, you must provide me with certain information (which you authorized Etsy to provide to me), such as your name, email address, postal address, payment information, and the details of the product that you're ordering. You may also choose to provide me with additional personal information (for a custom order of jewelry, for example), if you contact me directly.
Why I Need Your Information and How I Use It
I rely on a number of legal bases to collect, use, and share your information, including:
when you have provided your affirmative consent, which you may revoke at any time
as needed to provide my services, such as when I use your information to fulfil your order, to settle disputes, or to provide customer support;
if necessary to comply with a legal obligation or court order or in connection with a legal claim, such as retaining information about your purchases if required by tax law; and
as necessary for the purpose of my legitimate interests, if those legitimate interests are not overridden by your rights or interests, such as 1) providing and improving my services. I use your information to provide the services you requested and in my legitimate interest to improve my services; and 2) Compliance with the Etsy Seller Policy and Terms of Use. I use your information as necessary to comply with my obligations under the Etsy Seller Policy and Terms of Use.
Information Sharing and Disclosure
Information about my customers is important to my business. I share your personal information for very limited reasons and in limited circumstances, as follows:
Etsy. I share information with Etsy as necessary to provide you my services and comply with my obligations under both the Etsy Seller Policy and Etsy Terms of Use.
Service providers. I engage certain trusted third parties to perform functions and provide services to my shop, such as delivery companies. I will share your personal information with these third parties, but only to the extent necessary to perform these services.
Business transfers. If I sell or merge my business, I may disclose your information as part of that transaction, only to the extent permitted by law.
Compliance with laws. I may collect, use, retain, and share your information if I have a good faith belief that it is reasonably necessary to: (a) respond to legal process or to government requests; (b) enforce my agreements, terms and policies; (c) prevent, investigate, and address fraud and other illegal activity, security, or technical issues; or (d) protect the rights, property, and safety of my customers, or others.
Data Retention
I retain your personal information only for as long as necessary to provide you with my services and as described in my Privacy Policy. However, I may also be required to retain this information to comply with my legal and regulatory obligations, to resolve disputes, and to enforce my agreements. I generally keep your data for the following time period: 7 years.
Transfers of Personal Information Outside the EU
I may store and process your information through third-party hosting services in the US and other jurisdictions. As a result, I may transfer your personal information to a jurisdiction with different data protection and government surveillance laws than your jurisdiction.
Your Rights
If you reside in certain territories, including the EU, you have a number of rights in relation to your personal information. While some of these rights apply generally, certain rights apply only in certain limited cases. I describe these rights below:
Access. You may have the right to access and receive a copy of the personal information I hold about you by contacting me using the contact information below.
Change, restrict, delete. You may also have rights to change, restrict my use of, or delete your personal information. Absent exceptional circumstances (like where I am required to store data for legal reasons) I will generally delete your personal information upon request.
Object. You can object to (i) my processing of some of your information based on my legitimate interests and (ii) receiving marketing messages from me after providing your express consent to receive them. In such cases, I will delete your personal information unless I have compelling and legitimate grounds to continue using that information or if it is needed for legal reasons.
Complain. If you reside in the EU and wish to raise a concern about my use of your information (and without prejudice to any other rights you may have), you have the right to do so with your local data protection authority.
How to Contact Me
For purposes of EU data protection law, I, Casey Curlee, am the data controller of your personal information. If you have any questions or concerns, you may contact me at email@example.com. Alternately, you may mail me at:
Casey White, 731 Wooten Way, Blackfoot, Idaho 83221
I currently accept custom orders on a case by case basis. I will change or personalize an existing item if I have the pieces I need on hand, so feel free to ask!
I don't normally list the size of my rosaries and necklaces, because of the variety of ways people measure them. I do test fit my rosaries, and usually will mention in my listings if they would fit a child if they are small. My standard bead sizes is 4mm to 6mm and will fit most adults
Creating things is a huge coping mechanism for me. Because I have to craft fairly regularly, I choose to have my shop be a variety of items for a variety of people. In the future I hope to offer more options for different religions. I want my shop to feel like a happy, positive, and inclusive space. If as a buyer any of my items make you decide to shop somewhere else, I would still be more then happy to help you find what you need.
I do, and am willing to wholesale my product. But I never make anything exactly the same. I love offering variety and truly unique items, so if you are alright with selling items that are one of a kind, I would be more then happy to work with you!
A lot of it has to do with where I can get my supplies, some suppliers cost less the others, and some more, it also depends on the types of supplies I use, my freshwater pearls tend to cost more then my glass beads, and stone prices vary a lot as well
Unfortunately no. I have many different suppliers, and sometimes salvage broken jewelry for supplies. While many products are or do contain sterling silver and other hypoallergenic products, I cannot guarantee that all of the supplies in a piece are hypoallergenic. My products are not recommended for use by people with allergies.
People with metal allergies should not wear or purchase my product. In order to create unique pieces I get my supplies from all over, and they have different metal content I also have two dog companions, and while I do my best to insure my products do not come in contact with them, stray dog hair in my craft and packaging area is unavoidable. I do not use scents or oils, but cannot guarantee what the package may come in contact with after leaving my hands. I also will never include food stuffs. For specific allergies related to beads, please contact me and I will be happy to explain what pieces are made with what.
All my rosaries have the correct number of beads, but they do not have chain separating the decades. I use distinct colors, sizes, shapes and textures of beads to mark the separation. These different beads are referred to as the accent beads in my listings. The Our Father Bead is also included in this.
Well it's a fun little secret, but I am colorblind. Due to head/brain trauma my brain does not understand what I am seeing, so i see color incorrectly. In all honesty the colors look correct to me when I create a piece, but if you'd like to purchase one, and feel the colors are incorrect, please reach out to me before purchasing. I will work with you to try and find the correct color combination for you.


text:
Maintenance - Entry Level
National City, CA
FPI Management is currently looking for a Maintenance Technician to join our team!
OUR IDEAL CANDIDATE has experience in residential property management, hotel maintenance, construction, or painting. Has basic computer skills (email and internet). Is a self-motivated, customer service-oriented individual with exceptional attention to detail, and is someone who takes great pride in the quality of their work and is passionate about providing exemplary customer service!
MINIMUM REQUIREMENTS for consideration are a High School diploma or equivalent, English language proficiency (read, speak and write), and the ability to pass a full background check and drug screening (Note: As it relates to marijuana use, FPI will consider any applicable state law when dispositioning test results).
Why look at FPI for your next career step? We are one of the largest third-party property management companies in the Nation, an industry leader in both the Conventional and Affordable Housing spaces, with over 800 properties (over 100,000 units) across 15 states under our management. We offer comprehensive compensation and benefits packages, ongoing training and professional development, and plenty of growth opportunities. Come join Team FPI!
Interested? Click the Apply button above to learn more about this great opportunity to work with an industry leader!
EEO/EVerify Statements
FPI Management is an Equal Opportunity Employer. All qualified applicants are encouraged to apply. FPI Management participates in the E-Verify program.

subset: commoncrawl


text:
Report and Accounts of Historic England 2020–21
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.
There are no speakers to show.
There are no divisions to show.
Member's Registered Interests
There are no interests to show.
Associated documents
There are no documents to show.
Further information
There are no links to show.


text:
We, Web Creative India is a renowned company in the field of Web designing and mobile application in Uttar Pradesh. We offer services in Uttar Pradesh and working since last 8 years. We design the website using the technologies like Angular, Bootstrap, Java Script, AngularJS, Photoshop, Coral Draw, After Effect, Core PHP, Core Ignitor, Cake PHP, .Net, Java etc as per our client conscent.We offer the website design to clients and if the designed is passed by our client then the website is developed.
We offer service to promote the business for the people working in Kuwait through our below mentioned portal abbuads.com. We also offer services to promote business to thepeople of Uttar Pradesh through portal with address delhidistrictcentredelhi.com We promote the business without any prior website requirement mandate from the client.
We have made a number of products during our lucrative career. Here are some of them - Property Portal, News Portal, Government Mobile Application, School Management Software, Lead Management Software and Payroll Software. These are important in giving our client the right platform to excel in different business fields by developing the website in accordance to their needs.


text:
BEGIN:VCALENDAR VERSION:2.0 PRODID:-//18.104.22.168//NONSGML kigkonsult.se iCalcreator 2.26.9// CALSCALE:GREGORIAN METHOD:PUBLISH X-FROM-URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar X-WR-TIMEZONE:America/Los_Angeles BEGIN:VTIMEZONE TZID:America/Los_Angeles X-LIC-LOCATION:America/Los_Angeles BEGIN:STANDARD DTSTART:20231105T020000 TZOFFSETFROM:-0700 TZOFFSETTO:-0800 RDATE:20241103T020000 TZNAME:PST END:STANDARD BEGIN:DAYLIGHT DTSTART:20240310T020000 TZOFFSETFROM:-0800 TZOFFSETTO:-0700 RDATE:20250309T020000 TZNAME:PDT END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT UID:firstname.lastname@example.com/group/radweb/cgi-bin/radcalendar DTSTAMP:20231211T233930Z CATEGORIES;LANGUAGE=en-US:MIPS\,MIPS Seminar CONTACT:Ashley Williams\; email@example.com\; https://med.stanford.edu/ mips/events.html DESCRIPTION:
MIPS Seminar Series: strong> Translational Opportunities in Glycoscience\n
Carolyn Bertoz
zi\, PhD
\nDirector\, ChEM-H
\nAnne T. and Robert M. Bass Pr ofessor in the School of Humanities and Sciences
\nProfessor\, by cou rtesy\, of Chemical and Systems Biology
\nStanford University
Location: Zoom
\nWebinar URL: . https://stanford.zoom.us/j/94010708043
\nD ial: US: +1 650 724 9799 or +1 833 302 1536 (Toll Free)
\nWebinar ID : 940 1070 8043
\nPasscode: 659236
12:00pm – 12:45pm Seminar
& Discussion
\nRSVP Here
\nCell surface glycans constitute a rich biomol ecular dataset that drives both normal and pathological processes. Their "readers" are glycan-binding receptors that can engage in cell-cell intera ctions and cell signaling. Our research focuses on mechanistic studies of glycan/receptor biology and applications of this knowledge to new therape utic strategies. Our recent efforts center on pathogenic glycans in the t umor microenvironment and new therapeutic modalities based on the concept of targeted degradation.
\nC arolyn Bertozzi is the Baker Family Director of Stanford ChEM-H and the An ne T. and Robert M. Bass Professor of Humanities and Sciences in the Depar tment of Chemistry at Stanford University. She is also an Investigator of the Howard Hughes Medical Institute. Her research focuses on profiling cha nges in cell surface glycosylation associated with cancer\, inflammation a nd infection\, and exploiting this information for development of diagnost ic and therapeutic approaches\, most recently in the area of immuno-oncolo gy. She is an elected member of the National Academy of Medicine\, the Nat ional Academy of Sciences\, and the American Academy of Arts and Sciences. She also has been awarded the Lemelson-MIT Prize\, a MacArthur Foundation Fellowship\, the Chemistry for the Future Solvay Prize\, among many other s.
Hosted by: Katherine Ferrara\, PhD
Tickets: https://stanford.zoom.us/webinar/register/6816069496995/WN_V9HoN szmTq2h-lmrQcjtlQ.DTSTART;TZID=America/Los_Angeles:20210128T120000 DTEND;TZID=America/Los_Angeles:20210128T124500 LOCATION:Zoom - See Description for Zoom Link SEQUENCE:0 SUMMARY:MIPS Seminar – Carolyn Bertozzi\, PhD URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/mips-sem inar-carolyn-bertozzi-phd/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/Carolyn-Bertozzi-2017-Final-2-Credit-A merican-Chemical-Society-150x150.png\;150\;150\;1\,medium\;http://web.stan ford.edu/group/radweb/cgi-bin/radcalendar/wp-content/uploads/2019/10/Carol yn-Bertozzi-2017-Final-2-Credit-American-Chemical-Society-216x300.png\;216 \;300\;1\,large\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/ wp-content/uploads/2019/10/Carolyn-Bertozzi-2017-Final-2-Credit-American-C hemical-Society-737x1024.png\;640\;889\;1\,full\;http://web.stanford.edu/g roup/radweb/cgi-bin/radcalendar/wp-content/uploads/2019/10/Carolyn-Bertozz i-2017-Final-2-Credit-American-Chemical-Society.png\;1790\;2486\; X-TICKETS-URL:https://stanford.zoom.us/webinar/register/6816069496995/WN_V9 HoNszmTq2h-lmrQcjtlQ END:VEVENT BEGIN:VEVENT UID:firstname.lastname@example.com/group/radweb/cgi-bin/radcalendar DTSTAMP:20231211T233930Z CATEGORIES;LANGUAGE=en-US:PHIND\,PHIND Seminar Series CONTACT:Ashley Williams\; firstname.lastname@example.com DESCRIPTION:
PH IND Seminar Series: Maternal Trauma History\, Attachment Style\, and D epression Are Associated with Broad DNA Methylation Signatures in Infants< /em>\n
Thalia Robakis\, M.D.\, Ph.D.
\nAssociate Profes sor
\nDepartment of Psychiatry
\nMount Sinai School of Medicine< /p>\n
Location: Zoom
\nWebinar URL: https://stanford.zoom.us/s/95483174518
\nDial: US: +1 650 724 9799 or +1 833 302 1536 (Toll Free)
\nWebin ar ID: 954 8317 4518
\nPasscode: 179384
\n11:00am – 12:00pm Semi nar & Discussion
\nRSVP Here
Background: The early environment provid es many cues to young organisms that guide their development as they matur e. Maternal personality and behavior are an important aspect of the envir onment of the developing human infant. The molecular mechanisms by which these influences are exerted are not well understood. We attempted to ide ntify whether maternal traits could be associated with alterations in DNA methylation patterns in infants.\n
Methods: 32 women oversampled for
history of depression were recruited in pregnancy and provided informatio
n on depressive symptoms\, attachment style\, and history of early life ad
versity. Buccal cell DNA was obtained from their infants at six months of
age for a large-scale analysis of methylation patterns across 5×106<
/sup> individual CpG dinucleotides\, using clustering-based criteria for s
ignificance to control for multiple comparisons. Separately\, association
s between maternal depression\, attachment style\, and history of adversit
y and psychobehavioral outcomes in preschool-age children were examined.
p>\n Results: Tens of thousands of individual infant CpGs were alternati
vely methylated in association with each of the three studied maternal tra
its. Genes implicated in cell-cell communication\, developmental patterni
ng\, growth\, immune function/inflammatory response\, and neurotransmissio
n were identified. The result sets were highly coextensive among the three
maternal traits\, but areas of divergence exhibited intriguing parallels
with behavioral outcomes. Conclusions: Maternal personality traits
are an important aspect of the infant environment that shapes offspring d
evelopment in many ways. Infant genes that are epigenetically modified in
reponse to maternal traits are potential candidate mediators for these ef
fects. We have identified a large number of such genes and demonstrated p
arallels to clinically measurable outcomes in children.
ABOUT Dr. Robakis' research interests include the
effects of early life stress and disordered attachment on risk for psychia
tric illness in the perinatal period\, on alterations in metabolism and co
gnition\, and on psychobehavioral development in offspring. She is partic
ularly interested in using epigenetic marks to help identify the biologica
l pathways through which early life experiences exert their effects on out
comes in adulthood and intergenerationally. Hosted b
y: Garry Gold\, M.D. Tickets: https://stanford.zoom.us/webinar/register/2716074
MIPS Seminar Series: "Convergent\, translational research to
improve human health" Joseph M. DeSimone\, PhD Location: Zo
om 12:00pm – 12:45pm Seminar
& Discussion \n ABOUT DeSimone is
responsible for numerous breakthroughs in his career in areas including gr
een chemistry\, medical devices\, nanomedicine\, and 3D printing\, also co
-founding several companies based on his research. He has published over 3
50 scientific articles and is a named inventor on over 200 issued patents.
Additionally\, he has mentored 80 students through Ph.D. completion in hi
s career\, half of whom are women and members of underrepresented groups i
n STEM. In 2016 DeSimone was recognized by President Barack Obama with the
National Medal of Technology and Innovation\, the highest U.S. honor for
achievement and leadership in advancing technological progress. He is also
one of only 25 individuals elected to all three branches of the U.S. Nati
onal Academies (Sciences\, Medicine\, Engineering). DeSimone received his
B.S. in Chemistry in 1986 from Ursinus College and his Ph.D. in Chemistry
in 1990 from Virginia Tech. Hosted by: Katherine Fer
rara\, PhD Tickets: https://stanford.zoom.us/webinar/regist
er/1316068612555/WN_5MNzZlAnTvCMFY1dzOXDLw. Join us for t
he annual Precision Health & Integrated Diagnostics Symposium. This all-da
y virtual event will showcase the exciting PHIND work that is going on cam
pus wide. The featured presentations will be from current PHIND investigat
ors and Precision Health experts. We hope you can join us and look forward
to building the PHIND community together. Register Here
strong> Tickets: https://www.onlineregistrationce
nter.com/PHINDSymposium2021. MIPS Seminar Series: "Circulating Tumor DNA Bioma
rkers for Therapy Monitoring and Early Detection" Shan X. Wang\, PhD
\nDr. Robakis is a psychiatrist with clinical and research interests in perinatal mood disorders and in the contribution of early life experiences to adult mental health and illness. She comple ted her M.D. as well as a Ph.D. in developmental neurobiology at Columbia University's Medical Scientist Training Program\, residency training in ps ychiatry at Stanford University School of Medicine\, and a research fellow ship in perinatal mood disorders also at Stanford. She remained on the cli nical faculty at Stanford until 2019\, when she accepted a position at the Icahn School of Medicine at Mount Sinai\, where she is currently Associat e Clinical Professor of Psychiatry and Assistant Director of the Women's M ental Health Program.
\nSponsored by the PHIND Center and the Department of Radiology
\nSanjiv Sam Gambhir Pr ofessor of Translational Medicine and Chemical Engineering
\nDepartme nts of Radiology and Chemical Engineering
\nGraduate School of Busine ss (by Courtesy)
\nStanford University
\nWebinar URL: https://stanford.zoom.us/s/9846080 5010
\nDial: +1 650 724 9799 or +1 833 302 1536
\nWebinar ID : 984 6080 5010
\nPasscode: 809226
\nRSVP Here
\nIn many ways\, manufacturing processes define what's possible in society. Central to our interests in the DeSimone lab oratory are opportunities to make things using cutting-edge fabrication te chnologies that can improve human health. This lecture will describe adva nces in nano- / micro-fabrication and 3D printing technologies that we hav e made and employed toward this end. Using novel perfluoropolyether mater ials synthesized in our lab in 2004\, we invented the Particle Replication in Non-wetting Templates (PRINT) technology\, a high-resolution imprint l ithography-based process to fabricate nano- and micro-particles with preci se and independent control over particle parameters (e.g. size\, shape\, m odulus\, composition\, charge\, surface chemistry). PRINT brought the pre cision and uniformity associated with computer industry manufacturing tech nologies to medicine\, resulting in the launch of Liquidia Technologies (N ASDAQ: LQDA) and opening new research paths\, including to elucidate the i nfluence of specific particle parameters in biological systems (Proc. Natl . Acad. Sci. USA 2008)\, and to reveal insights to inform the design of va ccines (J. Control. Release 2018)\, targeted therapeutics (Nano Letters 20 15)\, and even synthetic blood (PNAS 2011). In 2015\, we reported the inv ention of the Continuous Liquid Interface Production (CLIP) 3D printing te chnology (Science 2015)\, which overcame major fundamental limitations in polymer 3D printing—slowness\, a very limited range of materials\, and an inability to create parts with the mechanical and thermal properties neede d for widespread\, durable utility. By rethinking the physics and chemist ry of 3D printing\, we created CLIP to eliminate layer-by-layer fabricatio n altogether. A rapid\, continuous process\, CLIP generates production-gr ade parts and is now transforming how products are manufactured in industr ies including automotive\, footwear\, and medicine. For example\, to help address shortages\, CLIP recently enabled a new nasopharyngeal swab for C OVID-19 diagnostic testing to go from concept to market in just 20 days\, followed by a 400-patient clinical trial at Stanford. Academic laboratori es are also using CLIP to pursue new medical device possibilities\, includ ing geometrically complex IVRs to optimize drug delivery and implantable c hemotherapy absorbers to limit toxic side effects. Vast opportunities exi st to use CLIP to pursue next-generation medical devices and prostheses. Moreover\, CLIP can improve current approaches\; for example\, the fabrica tion of an iontophoretic device we invented several years ago (Sci. Transl . Med. 2015) to drive chemotherapeutics directly into hard-to-reach solid tumors is now being optimized for clinical trials with CLIP. New design o pportunities also exist in early detection\, for example to improve specim en collection\, device performance (e.g. microfluidics\, cell sorting\, su pporting growth and studies with human organoids)\, and imaging (e.g. PET detectors\, ultrasound transducers). Here at Stanford\, we are pursuing n ew 3D printing advances\, including software treatment planning for digita l therapeutic devices in pediatric medicine\, as well as the design of a h igh-resolution printer capable of single-digit micron resolution to advanc e microneedle designs as a potent delivery platform for vaccines. The imp act of our work on human health ultimately relies on our ability to enable a convergent research program to take shape that allows for new connectio ns to be made among traditionally disparate disciplines and concepts\, and to ensure that we maintain a consistent focus on the translational potent ial of our discoveries and advances.
\nJoseph M. DeSimone is the Sanjiv Sam Gambhir Professor of Trans lational Medicine and Chemical Engineering at Stanford University. He hold s appointments in the Departments of Radiology and Chemical Engineering wi th a courtesy appointment in Stanford's Graduate School of Business. Previ ously\, DeSimone was a professor of chemistry at the University of North C arolina at Chapel Hill and of chemical engineering at North Carolina State University. He is also Co-founder\, Board Chair\, and former CEO (2014 – 2019) of the additive manufacturing company\, Carbon.
\nSponsored by: Molecular Imaging Program at Stan ford & the Department of Radiology
The agenda and speaker information are available
on the PHIND website. The event is fully virtual and the livestream lin
k will be posted on the PHIND website closer to the event.\n
\nLelan d T. Edwards Professor in the School of Engineering
\nProfessor of Ma terials Science & Engineering\, jointly of Electrical Engineering\, and by courtesy of Radiology (Stanford School of Medicine)
\nDirector\, Sta nford Center for Magnetic Nanotechnology
\nStanford University
Results: Tens of thousands of individual infant CpGs were alternati vely methylated in association with each of the three studied maternal tra its. Genes implicated in cell-cell communication\, developmental patterni ng\, growth\, immune function/inflammatory response\, and neurotransmissio n were identified. The result sets were highly coextensive among the three maternal traits\, but areas of divergence exhibited intriguing parallels with behavioral outcomes.\n
Conclusions: Maternal personality traits are an important aspect of the infant environment that shapes offspring d evelopment in many ways. Infant genes that are epigenetically modified in reponse to maternal traits are potential candidate mediators for these ef fects. We have identified a large number of such genes and demonstrated p arallels to clinically measurable outcomes in children.\n
Dr. Robakis' research interests include the effects of early life stress and disordered attachment on risk for psychia tric illness in the perinatal period\, on alterations in metabolism and co gnition\, and on psychobehavioral development in offspring. She is partic ularly interested in using epigenetic marks to help identify the biologica l pathways through which early life experiences exert their effects on out comes in adulthood and intergenerationally.\n
Hosted b
y: Garry Gold\, M.D.
Tickets: https://stanford.zoom.us/webinar/register/2716074 710252/WN_d0I3KpW6SCaxcpYHLk9aJw.DTSTART;TZID=America/Los_Angeles:20210216T110000 DTEND;TZID=America/Los_Angeles:20210216T120000 LOCATION:Zoom - See Description for Zoom Link SEQUENCE:0 SUMMARY:PHIND Seminar – Thalia Robakis\, M.D.\, Ph.D. URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/phind-se minar-thalia-robakis-m-d-ph-d/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/Robakis-headshot-150x150.jpg\;150\;150 \;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-c ontent/uploads/2019/10/Robakis-headshot-240x300.jpg\;240\;300\;1\,large\;h ttp://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-content/uploads /2019/10/Robakis-headshot.jpg\;498\;623\; X-TICKETS-URL:https://stanford.zoom.us/webinar/register/2716074710252/WN_d0 I3KpW6SCaxcpYHLk9aJw END:VEVENT BEGIN:VEVENT UID:email@example.com/group/radweb/cgi-bin/radcalendar DTSTAMP:20231211T233930Z CATEGORIES;LANGUAGE=en-US:MIPS\,MIPS Seminar CONTACT:Ashley Williams\; email@example.com\; https://med.stanford.edu/ mips/events.html DESCRIPTION:
MIPS Seminar Series: "Convergent\, translational research to improve human health"\n
Joseph M. DeSimone\, PhD
Location: Zo
12:00pm – 12:45pm Seminar
& Discussion
DeSimone is responsible for numerous breakthroughs in his career in areas including gr een chemistry\, medical devices\, nanomedicine\, and 3D printing\, also co -founding several companies based on his research. He has published over 3 50 scientific articles and is a named inventor on over 200 issued patents. Additionally\, he has mentored 80 students through Ph.D. completion in hi s career\, half of whom are women and members of underrepresented groups i n STEM. In 2016 DeSimone was recognized by President Barack Obama with the National Medal of Technology and Innovation\, the highest U.S. honor for achievement and leadership in advancing technological progress. He is also one of only 25 individuals elected to all three branches of the U.S. Nati onal Academies (Sciences\, Medicine\, Engineering). DeSimone received his B.S. in Chemistry in 1986 from Ursinus College and his Ph.D. in Chemistry in 1990 from Virginia Tech.\n
Hosted by: Katherine Fer
rara\, PhD
Tickets: https://stanford.zoom.us/webinar/regist er/1316068612555/WN_5MNzZlAnTvCMFY1dzOXDLw.DTSTART;TZID=America/Los_Angeles:20210225T120000 DTEND;TZID=America/Los_Angeles:20210225T124500 LOCATION:Zoom - See Description for Zoom Link SEQUENCE:0 SUMMARY:MIPS Seminar – Joseph M. DeSimone\, PhD URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/mips-sem inar-joseph-m-desimone-phd/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/Joe-Crop-5-150x150.jpg\;150\;150\;1\,m edium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-content /uploads/2019/10/Joe-Crop-5-240x300.jpg\;240\;300\;1\,large\;http://web.st anford.edu/group/radweb/cgi-bin/radcalendar/wp-content/uploads/2019/10/Joe -Crop-5-821x1024.jpg\;640\;798\;1\,full\;http://web.stanford.edu/group/rad web/cgi-bin/radcalendar/wp-content/uploads/2019/10/Joe-Crop-5.jpg\;1952\;2 436\; X-TICKETS-URL:https://stanford.zoom.us/webinar/register/1316068612555/WN_5M NzZlAnTvCMFY1dzOXDLw END:VEVENT BEGIN:VEVENT UID:firstname.lastname@example.com/group/radweb/cgi-bin/radcalendar DTSTAMP:20231211T233930Z CATEGORIES;LANGUAGE=en-US:PHIND CONTACT:Ashley Williams\; email@example.com\; https://med.stanford.edu/ phind/events/2021/2021-symposium.html DESCRIPTION:
Join us for t he annual Precision Health & Integrated Diagnostics Symposium. This all-da y virtual event will showcase the exciting PHIND work that is going on cam pus wide. The featured presentations will be from current PHIND investigat ors and Precision Health experts. We hope you can join us and look forward to building the PHIND community together.\n
Register Here strong>\n
Tickets: https://www.onlineregistrationce nter.com/PHINDSymposium2021.DTSTART;TZID=America/Los_Angeles:20210323T093000 DTEND;TZID=America/Los_Angeles:20210323T160500 LOCATION:Virtual Livestream SEQUENCE:0 SUMMARY:PHIND Symposium URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/phind-sy mposium-2/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/phind-150x150.png\;150\;150\;1\,medium \;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-content/uplo ads/2019/10/phind-300x205.png\;300\;205\;1\,large\;http://web.stanford.edu /group/radweb/cgi-bin/radcalendar/wp-content/uploads/2019/10/phind.png\;32 0\;219\; X-TICKETS-URL:https://www.onlineregistrationcenter.com/PHINDSymposium2021 END:VEVENT BEGIN:VEVENT UID:email@example.com/group/radweb/cgi-bin/radcalendar DTSTAMP:20231211T233930Z CATEGORIES;LANGUAGE=en-US:MIPS\,MIPS Seminar CONTACT:Ashley Williams\; email@example.com\; https://med.stanford.edu/ mips/events.html DESCRIPTION:
MIPS Seminar Series: "Circulating Tumor DNA Bioma rkers for Therapy Monitoring and Early Detection"\n
Shan X. Wang\, PhD
Location: Zoom
\nWebinar URL: https://stanford.zoom.us/s/93202777468
\nDi al: +1 650 724 9799 or +1 833 302 1536
\nWebinar ID: 932 0277 7468
\nPasscode: 851144
12:00pm – 12:45pm Seminar & Discussion
\nRSVP Here
\nInspired by Dr Sam Gambhir\, MIPS\, Canary Center\, and Stanfor d CCNE have pursued in vivo imaging and in vitro diagnostic tests for canc er therapeutic response or early detection\, respectively\, over the last 15+ years. Here I present two successful examples based on circulating tum or DNA (ctDNA) targets in plasma\, complementary to imaging modalities suc h as CT and Ultrasound.
We have developed a simple yet highly sens itive assay for the detection of actionable mutational targets such as Epi dermal Growth Factor Receptor (EGFR) and Kirsten rat sarcoma oncogene (KRA S) mutations in the plasma ctDNA from non-small cell lung cancer (NSCLC) p atients using giant magnetoresistive (GMR) nanosensors. Our assay achieves lower limits of detection compared to standard fluorescent PCR based assa ys\, and comparable performance to digital PCR methods. In 30 patients wit h metastatic disease and known EGFR mutation status at diagnosis\, our ass ay achieved 87.5% sensitivity for Exon19 deletion and 90% sensitivity for L858R mutation while retaining 100% specificity\; additionally\, our assay detected secondary T790M mutation resistance with 96.3% specificity while retaining 100% sensitivity. We re-sampled 13 patients undergoing tyrosine kinase inhibitor (TKI) therapy 2 weeks after initiation to assess respons e\, our GMR assay was 100% accurate in correlation with longitudinal clini cal outcome\, and the responders identified by the GMR assay had significa ntly improved progression free survival (PFS) compared to the non-responde rs. The GMR assay is low cost\, rapid\, and portable\, making it ideal for detecting actionable mutations at diagnosis and non-invasively monitoring treatment response in the clinic.\n
On another front\, we have also developed a highly sensitive and multiplexed assay for the detection of m ethylated ctDNA targets in plasma samples. Current diagnostic tests for li ver cancer in at-risk patients are cumbersome\, costly and inaccurate\, re sulting in a need for accurate blood-based tests. By devising a Layered An alysis of Methylated Biomarkers (LAMB) from the relevant big data\, we hav e discovered a set of DNA targets in the blood that accurately detects liv er cancer in these at-risk patients. This set of methylated targets was fo und by analyzing the genetic information of 3411 liver cancer patients and 1722 healthy people. Our results could lead to clinical adoption of liqui d biopsy tests for liver cancer surveillance in high-risk populations and the development of blood tests for other cancers.\n
\nProf. Wang directs the Center for Magnetic Nanotec hnology and is a leading expert in biosensors\, information storage and sp intronics. His research and inventions span across a variety of areas incl uding magnetic biochips\, in vitro diagnostics\, cancer biomarkers\, magne tic nanoparticles\, magnetic sensors\, magnetoresistive random access memo ry\, and magnetic integrated inductors. He has over 300 publications\, and holds 65 issued or pending patents in these and interdisciplinary areas. He was named an inaugural Fred Terman Fellow\, and was elected a Fellow of the Institute of Electrical and Electronics Engineers (IEEE) and a Fellow of American Physical Society (APS) for his seminal contributions to magne tic materials and nanosensors. His team won the Grand Challenge Exploratio n Award from Gates Foundation (2010)\, the XCHALLENGE Distinguished Award (2014)\, and the Bold Epic Innovator Award from the XPRIZE Foundation (201 7).
Dr. Wang cofounded three high-tech startups in Silicon Valley\ , including MagArray\, Inc. and Flux Biosciences\, Inc. In 2018 MagArray l aunched a first of its kind lung cancer early diagnostic assay based on pr otein cancer biomarkers and support vector machine (SVM). In 2019\, Flux B iosciences launched a human trial to offer at-home testing of fertility ba sed on hormones and magneto-nanosensors. Through his participation in the Center for Cancer Nanotechnology Excellence (as co-PI of the CCNE) and the Joint University Microelectronics Program (JUMP)\, he is actively engaged in the transformative research of healthcare and is developing emerging m emories for energy efficient computing.\n
sted by: Katherine Ferrara\, PhD
\nSponsored by: Molecular I maging Program at Stanford & the Department of Radiology
Tick ets: https://stanford. zoom.us/webinar/register/4016074679708/WN_F2zLmORfRh-Xuo4CWZOr7g.DTSTART;TZID=America/Los_Angeles:20210325T120000 DTEND;TZID=America/Los_Angeles:20210325T124500 LOCATION:Zoom - See Description for Zoom Link SEQUENCE:0 SUMMARY:MIPS Seminar – Shan X. Wang\, PhD URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/mips-sem inar-shan-x-wang-phd/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/shan-wang_profilephoto-150x150.jpg\;15 0\;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalenda r/wp-content/uploads/2019/10/shan-wang_profilephoto-300x300.jpg\;300\;300\ ;1\,large\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-con tent/uploads/2019/10/shan-wang_profilephoto.jpg\;350\;350\; X-TICKETS-URL:https://stanford.zoom.us/webinar/register/4016074679708/WN_F2 zLmORfRh-Xuo4CWZOr7g END:VEVENT BEGIN:VEVENT UID:email@example.com/group/radweb/cgi-bin/radcalendar DTSTAMP:20231211T233930Z CATEGORIES;LANGUAGE=en-US:PHIND\,PHIND Seminar Series CONTACT:Ashley Williams\; email@example.com DESCRIPTION:
PHIND Seminar Series: Impact of the Veterans Affairs National Abdominal Aortic Screening Program\n
Manuel Garcia-Toca\, M.D.
\nClinical Professor of Surgery
\nChief\, Division of Vas cular Surgery
\nSanta Clara Valley Medical Center (SCVMC)
r O. Aalami\, M.D.
\nClinical Associate Professor of Sur gery\, Vascular Surgery
\nLucile Packard Children's Hospital
Location: Zoom
\nWebinar URL: https://stanford.zoom.us/ s/98417624095
\nDial: US: +1 650 724 9799 or +1 833 302 1536 (To ll Free)
\nWebinar ID: 984 1762 4095
\nPasscode: 111283
11:00am – 12:00pm Seminar & Discussion
\nRSVP Here< /a>
Background : The U.S. Federal Government enacted the Screen for Abdominal Ao rtic Aneurysms Very Efficiently Act in January 2007. Simultaneously\, the Department of Veterans Affairs (VA) implemented a more inclusive AAA scree ning policy for veteran beneficiaries shortly afterwards.\n
\n< p>Our study aimed to evaluate the impact of the VA program on AAA detectio n rate and all-cause mortality compared to a cohort of patients whose aneu rysms were identified by other abdominal imaging.\n
We used a difference-in-differences regression model to eva luate the change in aneurysm detection rate and all-cause mortality five y ears before and eleven years after the VA implemented the screening policy in 2007.\n
We calculated survival estimates after AAA scr eening or non-screening imaging of patients with or without AAA diagnosis and used multivariate Cox regression model to evaluate mortality in patien ts with a positive AAA diagnosis adjusting for patient characteristics and comorbidities.\n
Results: We identified 3.9 million veterans with abdominal imaging\, a total of 303\,664 of whom were coded has having an AAA US screening between 2007 and 2018. An AAA di agnosis was made in 4.84% of the screening group vs. 1.3% in the non-scree ning imaging group P<0.001\, yet more aneurysms were found with g eneral imaging studies (50\,730 vs.15\,449) (Fig 1).\n
On Kaplan-Meier survival analysis\, patients with an AAA diagnosis had higher overall mortality than patients who screened normal\; patients with aneur ysms found with non-screening imaging had the highest mortality\, log-rank P<0.001 (Fig 2).\n
The difference in differences regression analysis\, showed that the absolute AAA detection rate was 1.5 5% higher (95% CI 1.2- 1.8)\, and the mortality was 13.89 % lower (95% CI 10.18 %-16.66 %) after the introduction of the screening program in 2007.< /p>\n
Multivariate Cox regression analysis in patients with AA A diagnosis (65-74-year-old) demonstrated a significantly lower 5-year mor tality [HR 0.45 (95% CI 0.43-0.48)] for patients in the US Screening group P<0.001.\n
Conclusions: In a nationwide analysis of VA patients\, implementation of AAA screening was associated with improved survival and a higher rate of AAA d iagnosis. These findings provide further support for this program's contin uation versus defaulting to incidental recognition following other abdomin al imaging.\n
\nDr. Garcia-Toca earned his medical degree at the Universidad Anahuac in Mexico 1999. He has a master's degree in Health Policy from Stanford Un iversity.
He received his general surgery training at th e Massachusetts General Hospital and Brown University in 2008. He then com pleted a Vascular Surgery fellowship at Northwestern University in 2010. D r. Garcia-Toca is board certified in both surgery and vascular surgery.\n
Dr. Garcia-Toca joined Stanford Vascular Surgery in 2015. He is currently Clinical Professor of Surgery in the Division of Vascular Surgery. Dr. Garcia-Toca had previously served as an Assistant Professor o f Surgery at Brown University. Dr. Garcia Toca is a Staff Surgeon at Sant a Clara Valley Medical Center in San Jose.\n
His research interests include new therapeutic strategies and outcomes for the manageme nt of vascular trauma\, cerebrovascular diseases\, dialysis access\, aorti c dissection and aneurysms.\n
\nDr. Aalami is a Clinical Associate Professor of Vascula r & Endovascular Surgery at Stanford University and the Palo Alto VA and s erves as the Lead Director of Stanford's Biodesign for Digital Health. He is the course director for Biodesign for Digital Health\, Building for Di gital Health and co-founder of the open source project\, CardinalKit\, de veloped to support sensor-based mobile research projects. His primary res earch focuses on clinically validating the sensors in smartphones and smar twatches in patients with cardiovascular disease to further precision heal th implementation.
Hosted by: Garry Gold\, M.D.
\nSponsored by the PHIND Center and the Department of Radiology< /em>
Tickets: https://stanford.zoom.us/webinar/register/8616164417003/WN_5z--vTmvRu6l62k OUd9sZg.DTSTART;TZID=America/Los_Angeles:20210420T110000 DTEND;TZID=America/Los_Angeles:20210420T120000 LOCATION:Zoom - See Description for Zoom Link SEQUENCE:0 SUMMARY:PHIND Seminar – Manuel Garcia-Toca\, M.D. & Oliver O. Aalami\, M.D. URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/phind-se minar-manuel-garcia-toca-m-d-oliver-o-aalami-m-d/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/2020.4_SpeakerMashUp_V2-01-150x150.png \;150\;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcal endar/wp-content/uploads/2019/10/2020.4_SpeakerMashUp_V2-01-300x150.png\;3 00\;150\;1\,large\;http://web.stanford.edu/group/radweb/cgi-bin/radcalenda r/wp-content/uploads/2019/10/2020.4_SpeakerMashUp_V2-01-1024x513.png\;640\ ;321\;1\,full\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp -content/uploads/2019/10/2020.4_SpeakerMashUp_V2-01.png\;1050\;526\; X-TICKETS-URL:https://stanford.zoom.us/webinar/register/8616164417003/WN_5z --vTmvRu6l62kOUd9sZg END:VEVENT BEGIN:VEVENT UID:email@example.com/group/radweb/cgi-bin/radcalendar DTSTAMP:20231211T233930Z CATEGORIES;LANGUAGE=en-US:MIPS\,MIPS Seminar CONTACT:Ashley Williams\; email@example.com\; https://med.stanford.edu/ mips/events.html DESCRIPTION:
MIPS Seminar Series: Emerging nanophotonic platforms for infectious disease diagnostics: Re-imagining the conventiona l microbiology toolkit\n
Jennifer Dionne\, PhD
\nSenior Associate Vice Provost for Research Platforms/Shared Facilitie s
\nAssociate Professor of Materia l Science and Engineering and\, by courtesy\, of Radiology (Molecular Imag ing Program at Stanford)
\nStanford University
Location: Zoom
\nWebinar URL: https://stanford.zoom.us/j/95883 654314
\nDial: +1 650 724 9799 or +1 833 302 1536
\nWebinar ID: 958 8365 4314
\nPasscode: 105586
12:00pm – 12:45pm Semina
r & Discussion
\nRSVP Here
\nWe present our research controlling light a t the nanoscale for infectious disease diagnostics\, including detecting b acteria at low concentration\, sensing COVID gene sequences\, and visualiz ing in-vivo inter-cellular forces. First\, we combine Raman spectroscopy a nd deep learning to accurately classify bacteria by both species and antib iotic resistance in a single step. We design a convolutional neural networ k (CNN) for spectral data and train it to identify 30 of the most common b acterial strains from single-cell Raman spectra\, achieving antibiotic tre atment identification accuracies exceeding 99% and species identification accuracies similar to leading mass spectrometry identification techniques. Our combined Raman-CNN system represents a proof-of-concept for rapid\, c ulture-free identification of bacterial isolates and antibiotic resistance . Second\, we describe resonant nanophotonic surfaces\, known as "metasur faces" that enable multiplexed detection of SARS-CoV-2 gene sequences. Our metasurfaces utilize guided mode resonances excited in high refractive in dex nanostructures. The high quality factor modes produce a large amplific ation of the electromagnetic field near the nanostructures that increase t he response to targeted binding of nucleic acids\; simultaneously\, the op tical signal is beam-steered for multiplexed detection. We describe how th is platform can be manufactured at scale for portable\, low-cost assays. F inally\, we introduce a new class of in vivo optical probes to mo nitor biological forces with high spatial resolution. Our design is based on upconverting nanoparticles that\, when excited in the near-infrared\, e mit light of a different color and intensity in response to nano-to-microN ewton forces. The nanoparticles are sub-30nm in size\, do not bleach or ph otoblink\, and can enable deep tissue imaging with minimal tissue autofluo rescence. We present the design\, synthesis\, and characterization of thes e nanoparticles both in vitro and in vivo\, focusing on the forces generat ed by the roundworm C. elegans as it feeds and digests its bacter ial food.
\nJennifer Dionne is the Senior Associate Vice Provost of Research Platforms/Shared Faciliti es and an associate professor of Materials Science and Engineering and\, b y courtesy\, of Radiology at Stanford. She is also an Associate Editor of Nano Letters\, director of the DOE-funded Photonics at Thermodynamic Limit s Energy Frontier Research Center\, and an affiliate faculty of the Wu Tsa i Neurosciences Institute\, the Institute for Immunity\, Transplantation\, and Infection\, and Bio-X. Jen received her B.S. degrees in Physics and S ystems Science and Mathematics from Washington University in St. Louis\, h er Ph. D. in Applied Physics at the California Institute of Technology in 2009\, and her postdoctoral training in Chemistry at Berkeley. Her resear ch develops nanophotonic methods to observe and control chemical and biolo gical processes as they unfold with nanometer scale resolution\, emphasizi ng critical challenges in global health and sustainability. Her work has b een recognized with the Alan T. Waterman Award\, a NIH Director's New Inno vator Award\, a Moore Inventor Fellowship\, the Materials Research Society Young Investigator Award\, and the Presidential Early Career Award for Sc ientists and Engineers\, and was featured on Oprah's list of "50 Things th at will make you say 'Wow'!". Beyond the lab\, Jen enjoys exploring the i ntersection of art and science\, long-distance cycling\, and reliving her childhood with her two young sons.
Hosted by: Kather
ine Ferrara\, PhD
\nSponsored by: Molecular Imaging Program at Stanford & the Department of Radiology
Tickets: https://stanford.zoom.us/webinar /register/7416069513520/WN_LIAnoCzYR8yLOnO-CDPgIQ.DTSTART;TZID=America/Los_Angeles:20210422T120000 DTEND;TZID=America/Los_Angeles:20210422T124500 LOCATION:Zoom - See Description for Zoom Link SEQUENCE:0 SUMMARY:MIPS Seminar – Jennifer Dionne\, PhD URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/mips-sem inar-jennifer-dionne-phd/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/jennifer-dionne_profilephoto-150x150.j pg\;150\;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radc alendar/wp-content/uploads/2019/10/jennifer-dionne_profilephoto-300x300.jp g\;300\;300\;1\,large\;http://web.stanford.edu/group/radweb/cgi-bin/radcal endar/wp-content/uploads/2019/10/jennifer-dionne_profilephoto.jpg\;350\;35 0\; X-TICKETS-URL:https://stanford.zoom.us/webinar/register/7416069513520/WN_LI AnoCzYR8yLOnO-CDPgIQ END:VEVENT BEGIN:VEVENT UID:firstname.lastname@example.com/group/radweb/cgi-bin/radcalendar DTSTAMP:20231211T233930Z CATEGORIES;LANGUAGE=en-US:Canary Center\,IBIIS\,MIPS\,PHIND\,Radiology\,RSL CONTACT:Marta Flory\; email@example.com DESCRIPTION:
Targeted violence co ntinues against Black Americans\, Asian Americans\, and all people of colo r. The department of radiology diversity committee is running a racial equ ity challenge to raise awareness of systemic racism\, implicit bias and re lated issues. Participants will be provided a list of resources on these t opics such as articles\, podcasts\, videos\, etc.\, from which they can ch oose\, with the "challenge" of engaging with one to three media sources pr ior to our session (some videos are as short as a few minutes). Participan ts will meet in small-group breakout sessions to discuss what they've lear ned and share ideas.\n
Please reach out to Marta Flory\, email@example.com with questions. For detail s about the session\, including recommended resources and the Zoom link\, please reach out to Meke Faaoso at m email@example.com.\n
Tickets: https://docs.google.com/spreadsheet s/d/1ehKqHm32peHcm7NQJ427OaKIa9JpfHVunjBk66etZGc/edit?usp=sharing.DTSTART;TZID=America/Los_Angeles:20210430T120000 DTEND;TZID=America/Los_Angeles:20210430T130000 LOCATION:Zoom SEQUENCE:0 SUMMARY:Racial Equity Challenge: Race in society URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/racial-e quity-challenge-race-in-society/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2021/04/shield-150x150.png\;150\;150\;1\,mediu m\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-content/upl oads/2021/04/shield.png\;225\;225\; X-TICKETS-URL:https://docs.google.com/spreadsheets/d/1ehKqHm32peHcm7NQJ427O aKIa9JpfHVunjBk66etZGc/edit?usp=sharing END:VEVENT BEGIN:VEVENT UID:firstname.lastname@example.com/group/radweb/cgi-bin/radcalendar DTSTAMP:20231211T233930Z CATEGORIES;LANGUAGE=en-US:MIPS\,MIPS Seminar CONTACT:Ashley Williams\; email@example.com\; https://med.stanford.edu/ mips/events.html DESCRIPTION:
Thomas Haywood\, PhD
\nHead of International Radiochemistry Collaborations
\nStanford University< /p>\n
Saurabh Kapure\, MBA
\nVice Presid ent\, Business Development (USA & APAC)
\nJubilant Biosys Limited
Jay Sheth\, MBA
\nManager Business De velopment\, Drug Discovery Services\, and CDMO
\nJubilant Biosys Limi ted
LOCATION: Zoom
\nMeeting U RL: h ttps://stanford.zoom.us/j/98108346345
\nDial: +1 650 724 9799 or +1 833 302 1536
\nMeeting ID: 981 0834 6345
\n Passcode: 397741
\nJubilant Biosys\, an integrated contr act research organization in India with business offices in Asia and North America\, is a leading collaborator for biotechnology and pharmaceutical companies\, with in-depth expertise in discovery informatics\, medicinal c hemistry\, structural biology\, and in vitro pharmacology service s. Jubilant Biosys provides comprehensive drug discovery services and cont ract research services\, from target discovery to candidate selection and with flexible business models (FFS\, FTE and risk shared). This seminar wi ll showcase case studies from recent Stanford projects and a discussion of future opportunities.
Sponsored by: Molecular Imagi ng Program at Stanford\, Department of RadiologyDTSTART;TZID=America/Los_Angeles:20210512T090000 DTEND;TZID=America/Los_Angeles:20210512T100000 LOCATION:Zoom - See Description for Zoom Link SEQUENCE:0 SUMMARY:MIPS Special Seminar – Jubilant Biosys URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/mips-spe cial-seminar-jubilant-biosys/ X-COST-TYPE:free X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/Headshots-for-Calendar-150x150.jpg\;15 0\;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalenda r/wp-content/uploads/2019/10/Headshots-for-Calendar.jpg\;210\;209\; END:VEVENT BEGIN:VEVENT UID:firstname.lastname@example.com/group/radweb/cgi-bin/radcalendar DTSTAMP:20231211T233930Z CATEGORIES;LANGUAGE=en-US:PHIND\,PHIND Seminar Series CONTACT:Ashley Williams\; email@example.com DESCRIPTION:
PHIND Seminar Series: Multi-Cancer Early Detection Screening Tests – "Liquid Biopsy Tests" – Are Here – But Will Payers Provide Insurance Coverage?\n
Patricia A. Deverka\, MD\, MS\, MBE<
br />\nExecutive Director
\nDeverka Consulting\, LLC
\n< p>Kathryn A. Phillips\, PhD
Location: Zoom
\nWebinar URL: https ://stanford.zoom.us/s/99194110894
\nDial: US: +1 650 724 9799 or +1 833 302 1536 (Toll Free)
\nWebinar ID: 991 9411 0894
\nPassc ode: 044958
11:00am – 12:00pm Seminar & Discussion
\nRSVP Here
\nThe emergence of Multi-Cancer Early Detection Screening Tests (MCED) – " liquid biopsy screening tests" – has generated enormous interest because t hey could fundamentally shift how cancer screening is done. One company is already offering an MCED test for clinical use as a "lab developed test" (LDT) – and thus addressing the question of "who will pay" has become urge nt. These tests offer potentially transformative screening and clinical be nefits\, but their characteristics present unique challenges to payer cove rage decision-making and generate concerns about the potentially high cost of widespread adoption.
We will present our ongoing work on exami ning the unique challenges that MCED present for payer coverage decision-m aking\, drawing on our extensive experience with coverage and reimbursemen t for new technologies. We will focus on identifying the evidence generati on strategies that could be pursued now to inform payer decision-making so that coverage policies can be developed that are appropriate and equitabl e for this ground-breaking technology.\n
\nDr. Deverka is the Executive Director at Deverka Consulting\, LLC where she focuses on helping biotechnology compan ies and start-ups develop evidence to support payer coverage and clinical adoption of innovative technologies. Her most recent projects have focuse d on breakthrough tests and drugs focused on population genomic screening\ , cancer\, and ultra-rare disorders. Prior to starting her consulting pra ctice\, Dr. Deverka has worked in the fields of health economics and outco mes research in both non-profit and for-profit settings as a researcher\, educator\, and department head. She has extensive experience with patient- centered outcomes research\, drug and diagnostic reimbursement planning\, cost- effectiveness analysis\, and bioethical issues surrounding the use o f new technologies. While working in academia and several non-profit firms \, she has participated in numerous NIH-funded studies to evaluate policy barriers to clinical integration of new genomic technologies and has publi shed extensively on strategies to promote evidence generation and data sha ring. She is a member of the National Human Genome Research Institute (NHG RI)'s Genomic Medicine Work Group and serves as a member of NHGRI's Adviso ry Council. Deverka has a medical degree from the University of Pittsburgh and is board certified in General Preventive Medicine and Public Health. She also has a master's degree in bioethics from the University of Pennsy lvania and completed a policy fellowship at Duke University's Institute fo r Genome Sciences and Policy.
\nKathryn A. Phillips founded and leads the UCSF Center for Translational and Policy Research on Personalized Medicine (TRANSPERS)\, which focuses on developing objective evidence on how to e ffectively\, efficiently\, and equitably implement precision/personalized medicine into health care. Kathryn has published over 150 peer-reviewed ar ticles in major journals including JAMA\, New England Journal of Medicine\, Science\, and Health Affairs. She ha s had continuous funding from NIH as a PI for over 25 years and was recent ly awarded a 5-year NIH grant to examine payer coverage and economic value for emerging genomic technologies (cell-free DNA tests and tests based on polygenic risk scores). Kathryn serves on the editorial boards for He alth Affairs\, Value in Health\, JAMA Internal Medicine< /em>\, Genetics in Medicine\; is a member of the National Academy of Medicine Roundtable on Genomics and Precision Health\; and has served on the governing Board of Directors for GenomeCanada and as an advisor to the FDA\, CDC\, and the President's Council of Advisors on Science and Tec hnology. She has also served as an advisor to many diagnostics\, sequencin g\, and pharmaceutical companies. Kathryn is Chair of the Global Econo mics and Evaluation of Clinical Sequencing Working Group\, and a memb er of an evidence review committee for the Institute for Clinical and Economic Review (ICER).
\n< p>Hosted by: Garry Gold\, M.D.
Tickets: https://stanford.zoom.us/webinar/re gister/9516200549922/WN_q4_OV6KhRe6MKb_cPEC3GQ.DTSTART;TZID=America/Los_Angeles:20210518T110000 DTEND;TZID=America/Los_Angeles:20210518T120000 LOCATION:Zoom - See Description for Zoom Link SEQUENCE:0 SUMMARY:PHIND Seminar – Patricia A. Deverka\, MD\, MS\, MBE & Kathryn A. Ph illips\, PhD URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/phind-se minar-patricia-a-deverka-md-ms-mbe-kathryn-a-phillips-phd/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/2020.5_SpeakerMashUp-150x126.jpg\;150\ ;126\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/ wp-content/uploads/2019/10/2020.5_SpeakerMashUp.jpg\;252\;126\; X-TICKETS-URL:https://stanford.zoom.us/webinar/register/9516200549922/WN_q4 _OV6KhRe6MKb_cPEC3GQ END:VEVENT BEGIN:VEVENT UID:firstname.lastname@example.com/group/radweb/cgi-bin/radcalendar DTSTAMP:20231211T233930Z CATEGORIES;LANGUAGE=en-US:MIPS\,MIPS Seminar CONTACT:Ashley Williams\; email@example.com\; https://med.stanford.edu/ mips/events.html DESCRIPTION:
MIPS Seminar Series: Image-guided focal therapy f or prostate cancer\n
Geoffrey Sonn\, MD
\nAssistant Professor of Urology and\, by courtesy\, of Radiology (Molecular Imaging Program at Stanford)
\n Stanford University Medical Center
Location: Zoom
\nWebinar URL: https://stanford.zoom.us/s/96126703618
\nDial: +1 650 724 97 99 or +1 833 302 1536
\nWebinar ID: 961 2670 3618
\nPasscode: 18 6059
12:00pm – 12:45pm Seminar & Discussion
\nRSVP Here
In re cent years\, prostate cancer treatment has increasingly focused on selecti ng patients who are most likely to benefit and reducing harms from treatme nt. This has been seen both in adoption of active surveillance for men wit h low-risk prostate cancer and emergence of image-guided focal ablative th erapy. While focal therapy causes fewer sexual and urinary side effects th an conventional prostate cancer treatments\, many questions remain about p roper patient selection\, treatment planning\, and follow up care.\n
Improvements in prostate MRI performance and i nterpretation have paved the way for adoption of focal therapy. However\, clinical challenges remain in prostate cancer imaging. This talk will desc ribe prostate cancer focal therapy\, discuss patient selection\, and highl ight the research efforts of my group to improve MRI interpretation to gui de biopsy and improve focal therapy performance.\n
\nGeoffrey Sonn\, MD is a urologic oncologist who spe cializes in treating patients with prostate and kidney cancer. He has a pa rticular interest in cancer imaging\, MRI-Ultrasound fusion targeted prost ate biopsy\, prostate cancer focal therapy\, and robotic surgery for prost ate and kidney cancer. He is the principal investigator of the first clini cal trial in Northern California to use MRI-guided focused ultrasound to t reat prostate cancer. The goal of this trial is to treat prostate cancer w ith fewer side effects than surgery or radiation.
Dr. Sonn was bor n in Washington State and lived there until leaving for college at Georget own. After graduating magna cum laude at Georgetown he returned to the Wes t Coast for medical school at UCLA. Following medical school\, Dr. Sonn co mpleted a 6-year urology residency at Stanford where he developed particul ar interests in the clinical care of patients with urologic cancers and re search in cancer imaging. Dr. Sonn completed a 2-year urologic oncology fe llowship at UCLA. Since completing his fellowship\, Dr. Sonn has been at S tanford as an assistant professor in urology. Dr. Sonn's research is devot ed to developing new cancer imaging techniques\, applying artificial intel ligence to find cancers on medical images\, and applying new methods to tr eat prostate cancer with fewer side effects.\n
by: Katherine Ferrara\, PhD
\nSponsored by: Molecular Imagin g Program at Stanford & the Department of Radiology
Tickets: https://stanford.zoom. us/webinar/register/8116097828282/WN_mfyC-_dUTwymWGqvmmF1zA.DTSTART;TZID=America/Los_Angeles:20210527T120000 DTEND;TZID=America/Los_Angeles:20210527T124500 LOCATION:Zoom - See Description for Zoom Link SEQUENCE:0 SUMMARY:MIPS Seminar – Geoffrey Sonn\, MD URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/mips-sem inar-geoffrey-sonn-md/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/geoffrey-sonn_profilephoto-150x150.jpg \;150\;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcal endar/wp-content/uploads/2019/10/geoffrey-sonn_profilephoto-300x300.jpg\;3 00\;300\;1\,large\;http://web.stanford.edu/group/radweb/cgi-bin/radcalenda r/wp-content/uploads/2019/10/geoffrey-sonn_profilephoto.jpg\;350\;350\; X-TICKETS-URL:https://stanford.zoom.us/webinar/register/8116097828282/WN_mf yC-_dUTwymWGqvmmF1zA END:VEVENT BEGIN:VEVENT UID:email@example.com/group/radweb/cgi-bin/radcalendar DTSTAMP:20231211T233930Z CATEGORIES;LANGUAGE=en-US:PHIND\,PHIND Seminar Series CONTACT:Ashley Williams\; email@example.com DESCRIPTION:
PHIND Seminar Series: Pervasive Computing With Everyday Devic es To Build & Sustain Resilience & Wellbeing\n
Pablo E. Paredes\, Ph
\nClinical Assistant Professor\, Psychiatry and Behavi oral Sciences and\, by courtesy\, Epidemiology and Population Health
\nStanford University
Zoom Webinar Details
\nWebinar URL: https ://stanford.zoom.us/s/99098874758
\nDial: US: +1 650 724 9799 or +1 833 302 1536 (Toll Free)
\nWebinar ID: 990 9887 4758
\nPassc ode: 784858
11:00am – 12:00pm Seminar & Discussion
\n12:00pm – 12:15pm Reception
\nRSVP Here
\nAs society progresses towards increasi ng pervasive computing levels\, I design and build technology-enabled solu tions to repurpose everyday devices to help people build resilience and gr ow wellbeing. I leverage biological and behavioral knowledge to design sys tems that balance user needs and health outcomes while mitigating surveill ance and agency risks. In this talk\, I present my research on efficacious and engaging sensors and interventions necessary in the population and pu blic health domains. I share a series of research projects exploring and v alidating novel ideas on passive sensors – less dependent on subjective su rveys or wearables – and subtle interventions that minimize workflow disr uption. I show the promise of repurposing existing signals from computing peripherals (i.e.\, mouse and trackpad) or cars (steering wheel) into "sen sorless" sensors and repurposing existing media as just-in-time micro-inte rventions that can work across multiple scenarios and populations. I discu ss how these data could be used in collaboration with domain experts to st udy topics as varied as the interaction between stress and productivity in office workers\, burnout prevention among clinical practitioners\, or the prevention of depression among rural health workers. Finally\, grounded i n theories from neuroscience and behavioral economics\, I propose the evol ution of everyday "mundane" devices\, such as chairs\, desks\, cars\, or e ven urban lights\, into adaptive and autonomous wellbeing-optimizing inter ventions. I close with a discussion of the research needed to systematical ly study ethics in pervasive technology for resilience\, and wellbeing.
\nPablo Paredes earned his Ph. D. in Computer Science from the University of California\, Berkeley\, in 2 015 with Prof. John Canny. He is currently a Clinical Assistant Professor in the Psychiatry and Behavioral Sciences Department and the Epidemiology and Population Health Department (by courtesy) at the Stanford University School of Medicine. He leads the Pervasive Wellbeing Technology Lab\, whic h houses a diverse group of students from multiple departments such as com puter science\, electrical engineering\, mechanical engineering\, anthropo logy\, neuroscience\, and linguistics. Before joining the School of Medici ne\, Dr. Paredes was a Postdoctoral Researcher in the Computer Science Dep artment at Stanford University with Prof. James Landay. During his Ph.D. c areer\, he held internships on behavior change and affective computing at Microsoft Research and Google. He has been an active associate editor for the Interactive\, Mobile\, Wireless\, and Ubiquitous Technology Journal (I MWUT) and a reviewer and editor for multiple top CS and medical journals. Before 2010\, he was a senior strategic manager with Intel in Sao Paulo\, Brazil\, a lead product manager with Telefonica in Quito\, Ecuador\, and a n entrepreneur in his native Ecuador and\, more recently\, in the US. In t hese roles\, he has had the opportunity to hire and closely evaluate desig ners\, engineers\, business people\, and researchers in telecommunications and product development. During his academic career\, Dr. Paredes has adv ised close to 40 mentees\, including postdocs\, Ph.D.\, master's\, and und ergraduate students\, collaborated with colleagues from multiple departmen ts across engineering\, medicine\, and the humanities\, and raised funding from NSF\, NIH\, and large multidisciplinary intramural research projects .
Hosted by: Garry Gold\, M.D.
\nSpons ored by the PHIND Center and the Department of Radiology
Tick ets: https://stanford. zoom.us/webinar/register/8316220421859/WN_thRILWbcQK2h9DllQXNjRQ.DTSTART;TZID=America/Los_Angeles:20210615T110000 DTEND;TZID=America/Los_Angeles:20210615T120000 LOCATION:Zoom - See description for more information SEQUENCE:0 SUMMARY:PHIND Seminar – Pablo E. Paredes\, Ph.D. URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/phind-se minar-pablo-e-paredes-castro-ph-d/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/self_picture_pablo_flowers-150x150.jpe g\;150\;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radca lendar/wp-content/uploads/2019/10/self_picture_pablo_flowers-225x300.jpeg\ ;225\;300\;1\,large\;http://web.stanford.edu/group/radweb/cgi-bin/radcalen dar/wp-content/uploads/2019/10/self_picture_pablo_flowers-768x1024.jpeg\;6 40\;853\;1\,full\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar /wp-content/uploads/2019/10/self_picture_pablo_flowers.jpeg\;2448\;3264\; X-TICKETS-URL:https://stanford.zoom.us/webinar/register/8316220421859/WN_th RILWbcQK2h9DllQXNjRQ END:VEVENT BEGIN:VEVENT UID:email@example.com/group/radweb/cgi-bin/radcalendar DTSTAMP:20231211T233930Z CATEGORIES;LANGUAGE=en-US:PHIND\,PHIND Seminar Series CONTACT:Ashley Williams\; email@example.com DESCRIPTION:
PHIND & CDH Seminar: "The Invisible Future of Health Monitoring"\n
Join Stanford CDH and PHIND on Wednesday\, June 23rd at 3:15 PM PDT t o hear some of the industry's leading experts talk about embedded sensors\ , longitudinal data collection\, the future of remote monitoring\, and rea l-world applications of precision health technologies. The panel will feat ure: Nicolas Genain\, MS\, Withings\; John O Moore MD\, PhD\, Fitbit H ealth Solutions at Google\; Pablo Paredes\, PhD\, MBA\, MS\, Stanford Un iversity\; and Michael Synder\, PhD\, Stanford University. The discussion will be moderated by Jun (Alex) Gao\, MS\, Samsung America.\n
Zoom Webinar Details
\nWebinar URL: https://stanford.zoom.us/s/96984014176
\nDial: US: +1 650 7 24 9799 or +1 833 302 1536 (Toll Free)
\nWebinar ID: 969 8401 4176\nPasscode: 375941
3:15pm – 4:15pm: Panel Discussion
\nRSVP Here
Sponsored by the PHIND Center and Center for Digital Health\n
Tickets: https://stanford.zoom.us/w ebinar/register/7016228432975/WN_7RpA06gIQICRCH6bzQjt3w.DTSTART;TZID=America/Los_Angeles:20210623T151500 DTEND;TZID=America/Los_Angeles:20210623T161500 LOCATION:Zoom - See Description for Zoom Link SEQUENCE:0 SUMMARY:"The Invisible Future of Health Monitoring" – PHIND & CDH Seminar URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/the-invi sible-future-of-health-monitoring-phind-cdh-seminar/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/June-23rd-webinar-external-calendar-ti le-01-150x150.png\;150\;150\;1\,medium\;http://web.stanford.edu/group/radw eb/cgi-bin/radcalendar/wp-content/uploads/2019/10/June-23rd-webinar-extern al-calendar-tile-01-300x205.png\;300\;205\;1\,large\;http://web.stanford.e du/group/radweb/cgi-bin/radcalendar/wp-content/uploads/2019/10/June-23rd-w ebinar-external-calendar-tile-01-1024x700.png\;640\;438\;1\,full\;http://w eb.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-content/uploads/2019/1 0/June-23rd-webinar-external-calendar-tile-01.png\;1251\;855\; X-TICKETS-URL:https://stanford.zoom.us/webinar/register/7016228432975/WN_7R pA06gIQICRCH6bzQjt3w END:VEVENT BEGIN:VEVENT UID:firstname.lastname@example.com/group/radweb/cgi-bin/radcalendar DTSTAMP:20231211T233930Z CATEGORIES;LANGUAGE=en-US:AIMI\,IBIIS\,Radiology\,RSL CONTACT: DESCRIPTION:
Radiology Department-Wide Research Meeting\n
• Research Announcements
\n• Mirabela Rusu\, PhD – Learning MRI Signatures of Aggressive Prostate Cancer: Bridging the Gap between Digital Pathologists and Digital Radiologists
\n• Akshay Chaudhari\, PhD – Data-Efficient Machine Learning for Medical Imaging
Location: Zoom – Details can be found here: https://radresearch.stanford.edu
\nMeetings will be the 3rd F riday of each month.
Hosted by: Kawin Setsompop\, Ph
\nSponsored by: the the Department of Radiology
PHIND Seminar Series: Plastic-based sensors for wearable tech nologies: fundamentals and applications\n
Alberto Salleo\, Ph.D.
\nProfessor of Material Sciences and Engineering
\nStanford University
Zoom Webinar Details
\nWebinar URL: https://stanford.zoom.us/s/9264668670 5
\nDial: US: +1 650 724 9799 or +1 833 302 1536 (Toll Free)
\nWebinar ID: 926 4668 6705
\nPasscode: 270341
11:00am – 12
:00pm Seminar & Discussion
\nRSVP Here
\nThe continuous monitoring of hu man health can greatly benefit from devices that can be worn comfortably o r seamlessly integrated in household objects\, constituting "health-center ed" domotics. One of the key aspects for these devices to be successful is to be invisibly integrated and disappear in the background of our lives. Our group works on thin film devices made with plastic materials that can be used for electrochemically sensing of common analytes from easily acces sible bodily fluids (e.g. sweat\, saliva\, urine) and can be easily multip lexed. I will describe electrochemical transistors that detect ionic speci es either directly present in body fluids or resulting from a selective en zymatic reaction (e.g. ammonia from creatinine) at physiological levels. I will also show that non-charged molecules can be detected by making use o f custom-processed polymer membranes that act as "synthetic enzymes". Usin g these membranes in conjunction with electrochemical transistors we demon strate that we are able to measure physiological levels of cortisol in rea l human sweat. Importantly\, transistors can amplify signals and I will sh ow what architectures must be used to observe 1000x amplification of sensi ng currents.
Finally we have developed a process that allows us to fabricate sensor arrays on flexible substrates thereby opening the door t owards ultra-thin\, flexible sensor arrays for wearable technologies.\n
\nAlberto Salleo is currently F ull Professor of Materials Science and Department Chair at Stanford Univer sity. Alberto Salleo holds a Laurea degree in Chemistry from La Sapienza and graduated as a Fulbright Fellow with a PhD in Materia ls Science from UC Berkeley in 2001. From 2001 to 2005 Salleo was first po st-doctoral research fellow and successively member of research staff at X erox Palo Alto Research Center. In 2005 Salleo joined the Materials Scienc e and Engineering Department at Stanford as an Assistant Professor in 2006 . Salleo is a Principal Editor of MRS Communications since 2011.While at S tanford\, Salleo won the NSF Career Award\, the 3M Untenured Faculty Award \, the SPIE Early Career Award\, the Tau Beta Pi Excellence in Undergradua te Teaching Award\, and the Gores Award for Excellence in Teaching\, Stanf ord's highest teaching award. He has been a Thomson Reuters Highly Cit ed Researcher since 2015\, recognizing that he ranks in the top 1% ci ted researchers in his field.
Hosted by: Garry Gold\
\nSponsored by the PHIND Center and the Department of Radiology
Tickets: https://stanford.zoom.us/webinar/register/2816249009305/WN_lUez gp98RMKzD7rC6oeRFg.DTSTART;TZID=America/Los_Angeles:20210720T110000 DTEND;TZID=America/Los_Angeles:20210720T120000 LOCATION:Zoom - See Description for Zoom Link SEQUENCE:0 SUMMARY:PHIND Seminar – Alberto Salleo\, Ph.D. URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/phind-se minar-alberto-salleo-ph-d/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/alberto-salleo_profilephoto-150x150.jp g\;150\;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radca lendar/wp-content/uploads/2019/10/alberto-salleo_profilephoto-300x300.jpg\ ;300\;300\;1\,large\;http://web.stanford.edu/group/radweb/cgi-bin/radcalen dar/wp-content/uploads/2019/10/alberto-salleo_profilephoto.jpg\;350\;350\; X-TICKETS-URL:https://stanford.zoom.us/webinar/register/2816249009305/WN_lU ezgp98RMKzD7rC6oeRFg END:VEVENT BEGIN:VEVENT UID:firstname.lastname@example.com/group/radweb/cgi-bin/radcalendar DTSTAMP:20231211T233930Z CATEGORIES;LANGUAGE=en-US:PHIND\,PHIND Seminar Series CONTACT:Ashley Williams\; firstname.lastname@example.com\; https://med.stanford.edu/ phind/events/2021.html DESCRIPTION:
PHIND Seminar Series: Peace of mind for those affected by stroke< /p>\n
Orestis Vardoulis\, Ph.D.
\nCo-Founder & CEO
\nZeit Medical
Zoom Webinar Details\nWebinar URL: https://stanford.zoom.us/s/94427469356
\nD ial: US: +1 650 724 9799 or +1 833 302 1536 (Toll Free)
\nWebinar ID : 944 2746 9356
\nPasscode: 999031
11:00am – 12:00pm Seminar
& Discussion
\n12:00pm – 12:15pm Reception
\nR SVP Here
There is a growing population of over 10 million Americans that live with an elevat ed risk of having a stroke.\n
Each year approximately 1 million Amer icans survive a stroke or a ministroke\, often severely affected by its de bilitating effects. A more disabling stroke frequently occurs after the se minal events\, leaving patients and their families scarred for life.\n
TIME = BRAIN. Early hospital presentation is the most critical determin ant in good stroke outcomes. However\, most patients arrive at the hospita l often hours after the event\, with less than 10% receiving any form of t reatment (thrombolysis / thrombectomy).\n
As a result\, at risk indi viduals struggle daily with the fear\, a stroke might happen during night- time or when they are alone. Unfortunately a stroke that goes unnoticed fo r hours\, is most often not treatable due to the lack of salvageable tissu e.\n
To alleviate that fear\, we are creating an AI-powered\, smart- headband that analyzes brain waves to detect the onset of an event immedia tely\, and alert the patient\, caregivers and 911.\n
Our stroke dete ction AI has already been shown to detect ischemia during high-risk surger ies with 90% sensitivity and no false positives.\n
We have received FDA breakthrough designation for our solution and are currently running a pilot human factors and signal quality study.\n
Our vision is to pro vide peace of mind and optimal brain health for everyone.\n
\n< p>ABOUT
em>Hosted by: Garry Gold\, M.D.
\nSponsored by the PHIND Cen ter and the Department of Radiology
Tickets: https://stanford.zoom.us/webinar/regis ter/3016264733187/WN_i3dqwzHERYOfa7-Y87t7PQ.DTSTART;TZID=America/Los_Angeles:20210817T110000 DTEND;TZID=America/Los_Angeles:20210817T120000 LOCATION:Zoom - See Description for Zoom Link SEQUENCE:0 SUMMARY:PHIND Seminar – Orestis Vardoulis\, Ph.D. URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/phind-se minar-orestis-vardoulis-ph-d/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/ovardoulis_hshot_1-150x150.png\;150\;1 50\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp -content/uploads/2019/10/ovardoulis_hshot_1-300x300.png\;300\;300\;1\,larg e\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-content/upl oads/2019/10/ovardoulis_hshot_1.png\;640\;640\;\,full\;http://web.stanford .edu/group/radweb/cgi-bin/radcalendar/wp-content/uploads/2019/10/ovardouli s_hshot_1.png\;716\;716\; X-TICKETS-URL:https://stanford.zoom.us/webinar/register/3016264733187/WN_i3 dqwzHERYOfa7-Y87t7PQ END:VEVENT BEGIN:VEVENT UID:firstname.lastname@example.com/group/radweb/cgi-bin/radcalendar DTSTAMP:20231211T233930Z CATEGORIES;LANGUAGE=en-US:CME\,CME Radiology Grand Rounds\,Radiology CONTACT:Tricia Hatcliff\; 650-498-7359\; firstname.lastname@example.com DESCRIPTION:
Simon R. Cherry\, PhD
\nBi omedical Engineering & Radiology
\nUC Davis
Join fr
om PC\, Mac\, Linux\, iOS or Android: https://stanford.zoom.us/j
\nMeeting ID: 600 003 703
\nPassword: 566048
\nOr iPhone one-tap (US Toll): +1833 3021536\,\,600003703# or +16507249799\,\,600003703#
\nOr Telephone:\nDial: +1 650 724 9799 (US\, Canada\, Caribbean Toll) or +1 833 302 1 536 (US\, Canada\, Caribbean Toll Free)
\nInternational numbers avail able: https://stanford.zoo m.us/u/acuqphnvqT
Positron emission tomography (PET) allows for sensitive and quantitative m easurement of physiology\, metabolism and molecular targets noninvasively in the human body. However\, typical clinical PET scanners capture less t han 1% of the available signal produced in the body. PET scanners also ar e not currently capable of precisely determining the location at which a p articular decay occurs. These limitations present opportunities for furthe r innovation that ultimately will impact molecular imaging research and di agnostic imaging with PET. This presentation focuses on 1) total-body PET imaging which greatly improves signal collection\, allowing radiotracer k inetics to be assessed across the entire human body for the first time\, a nd 2) the development of detector technologies that have a timing precisio n of ~ 30 picoseconds\, enabling direct localization of radiotracer decays without tomographic reconstruction.\n
Simon R. Cherry\, Ph.D. received his B.Sc.(Hons) in Physics wit h Astronomy from University College London in 1986 and a Ph.D. in Medical Physics from the Institute of Cancer Research\, University of London in 19 89. After a postdoctoral fellowship at UCLA\, he joined the faculty in th e Department of Molecular and Medical Pharmacology\, also at UCLA\, in 199 3. In 2001\, Dr. Cherry joined UC Davis and established the Center for Mol ecular and Genomic Imaging\, which he directed from 2004-2016. Currently D r. Cherry is Distinguished Professor in the Departments of Biomedical Engi neering and Radiology at UC Davis.\n
Dr. Cherry's research interests center around biomedical imaging and in particular the development and ap plication of in vivo molecular imaging systems. His major accomplishments have been in developing systems for positron emission tomography (PET)\, in particular the invention of the microPET technology that was subsequent ly widely adopted in academia and industry and as co-leader of the EXPLORE R consortium which has developed the world's first total-body PET scanner. He also has contributed to detector technology innovations for PET\, con ducted early biomedical studies using Cerenkov luminescence\, and develope d the first proof-of-concept hybrid PET/MRI (magnetic resonance imaging) s ystems.\n
Dr. Cherry is a founding member of the Society of Molecula r Imaging and an elected fellow of six professional societies\, including the Institute for Electronic and Electrical Engineers (IEEE) and the Biome dical Engineering Society (BMES). He served as Editor-in-Chief of the jour nal Physics in Medicine and Biology from 2011-2020. Dr. Cherry received th e Academy of Molecular Imaging Distinguished Basic Scientist Award (2007)\ , the Society for Molecular Imaging Achievement Award (2011) and the IEEE Marie Sklodowska-Curie Award (2016). In 2016\, he was elected as a membe r of the National Academy of Engineering and in 2017 he was elected to the National Academy of Inventors. Dr. Cherry is the author of more than 240 peer-reviewed journal articles\, review articles and book chapters in the field of biomedical imaging. He is also lead author of the widely-used te xtbook "Physics in Nuclear Medicine".DTSTART;TZID=America/Los_Angeles:20210910T120000 DTEND;TZID=America/Los_Angeles:20210910T130000 LOCATION:LKSC 101/102 & Zoom - See Description for Zoom Link @ 291 Campus D rive\, Stanford\, CA 94305 SEQUENCE:0 SUMMARY:CME Grand Rounds Sanjiv Sam Gambhir Lectureship – Simon Cherry\, Ph D URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/cme-gran d-rounds-sanjiv-sam-gambhir-lectureship-simon-cherry-phd/ X-COST-TYPE:free X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2021/07/simon_cherry_website-150x150.jpg\;150\ ;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/ wp-content/uploads/2021/07/simon_cherry_website-269x300.jpg\;269\;300\;1\, large\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-content /uploads/2021/07/simon_cherry_website.jpg\;520\;580\; END:VEVENT BEGIN:VEVENT UID:firstname.lastname@example.com/group/radweb/cgi-bin/radcalendar DTSTAMP:20231211T233930Z CATEGORIES;LANGUAGE=en-US:PHIND\,PHIND Seminar Series CONTACT:Ashley Williams\; firstname.lastname@example.com DESCRIPTION:
PHIND Seminar Series: Towards precision diagnostic and prediction of food allergy\n
Sindy KY Tang\, Ph.D.
\nAssociate Profess or of Mechanical Engineering\, Senior Fellow at the Woods Institute for th e Environment and Professor\, by courtesy\, of Radiology – PHIND Center
\nStanford University
Location: Zoom
\nWebinar URL: https://stanford.zoom.us/s/919329663 34
\nDial: US: +1 650 724 9799 or +1 833 302 1536 (Toll Free)
\nWebinar ID: 919 3296 6334
\nPasscode: 383071
11:00am – 1
2:00pm Seminar & Discussion
\nRSVP Here
\nFood allergy has reached epide mic proportions. Accurate in vitro methods that are efficient and easy to use to identify offending food allergens are lacking. Oral food challenge\ , the gold standard for food allergy assessment\, is often not performed a s it places the patient at risk of anaphylaxis. As such\, food allergy is often identified only after an adverse reaction that could be life-threate ning. Our long-term goal is to develop a food allergy diagnostic test that is accurate\, safe\, rapid\, and accessible\, so that food allergy can be easily identified prior to the occurrence of an adverse reaction\, and th at the efficacy of immunotherapy for food allergy can be tracked more effe ctively. This talk will discuss our recent work on developing such a test. Our approach is based on the Basophil Activation Test (BAT)\, which measu res the activation of basophils in whole blood after stimulation with spec ific food allergens ex vivo. The BAT has been shown to be highly predictiv e of allergic reactions. However\, the need for flow cytometry has limited its broader use. We are developing a miniaturized\, standalone version of the BAT. We envision that the test can be used at the point of care\, suc h as the doctor's office or at a local pharmacy.
\nProf. Sindy KY Tang is the Kenneth and Barbara Oshm an Faculty Scholar and Associate Professor of Mechanical Engineering and b y courtesy of Radiology (Precision Health and Integrated Diagnostics) at S tanford University. She received her Ph.D. from Harvard University in Engi neering Sciences under the supervision of Prof. George Whitesides. Her lab at Stanford works on the fundamental understanding of fluid mechanics and mass transport in micro-nano systems\, and the application of this knowle dge towards problems in biology\, rapid diagnostics for health and environ mental sustainability. The current areas of focus include the flow physics of confined micro-droplets using experimental and machine learning method s\, interfacial mass transport and self-assembly\, and ultrahigh throughpu t opto-microfluidic systems for disease diagnostics\, water and energy sus tainability\, and single-cell wound healing studies. She was a Stanford Bi odesign Faculty Fellow in 2018. Dr. Tang's work has been recognized by mul tiple awards including the NSF CAREER Award\, 3M Nontenured Faculty Award\ , the ACS Petroleum Fund New Investigator Award\, and invited lecture at t he Nobel Symposium on Microfluidics in Sweden. Website: http://web.stanford.edu/group/tanglab/< /p>\n
Hosted by: Garry Gold\, M.D.
\nSponsor ed by the PHIND Center and the Department of Radiology
Ticket s: https://stanford.zo om.us/webinar/register/1216286302579/WN_3iFMsumAT9iKlV5G1Vr9zA.DTSTART;TZID=America/Los_Angeles:20210921T110000 DTEND;TZID=America/Los_Angeles:20210921T120000 LOCATION:Zoom - See Description for Zoom Link SEQUENCE:0 SUMMARY:PHIND Seminar – Sindy KY Tang\, Ph.D. URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/phind-se minar-sindy-ky-tang-ph-d/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/sindy-tang_profilephoto-150x150.jpg\;1 50\;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radcalend ar/wp-content/uploads/2019/10/sindy-tang_profilephoto-300x300.jpg\;300\;30 0\;1\,large\;http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-c ontent/uploads/2019/10/sindy-tang_profilephoto.jpg\;350\;350\; X-TICKETS-URL:https://stanford.zoom.us/webinar/register/1216286302579/WN_3i FMsumAT9iKlV5G1Vr9zA END:VEVENT BEGIN:VEVENT UID:firstname.lastname@example.com/group/radweb/cgi-bin/radcalendar DTSTAMP:20231211T233930Z CATEGORIES;LANGUAGE=en-US:MIPS\,MIPS Seminar CONTACT:Ashley Williams\; firstname.lastname@example.com\; https://med.stanford.edu/ mips/events.html DESCRIPTION:
MIPS Seminar Series: Predicting and Prevent ing Fetal and Neonatal Pathology: Looking Back and Looking Forward\n
David K. Ste
venson\, MD
\nThe Harold K. Faber Professor of Pediatrics\, Senio r Associate Dean\, Maternal and Child Health and Professor\, by courtesy\, of Obstetrics and Gynecology
\nLucile Packard Children's Hospital
Zoom Webinar Details
\nWebi nar URL: https://stanford.zoom.us/s/94584828060
\nDial: +1 65 0 724 9799 or +1 833 302 1536
\nWebinar ID: 945 8482 8060
\nPass code: 481874
12:00pm – 12:45pm Seminar & Discussion
\nRSVP Here
\nThe importance of minimally invasive technologies for interrogating the fetus and newborn\, as well as of knowing where a biologic system is heade d\, not just where it has been\, when trying to predict and prevent acquir ed diseases\, will be discussed. Examples of such technologies\, such as trace gas analysis and optical reporting of biologic phenomena\, and their application to model systems and the human newborn will be presented. Th e role of advanced computational approaches for the integration and interp retation of large amounts of data derived from these new measurement tools will be emphasized.
\nDr. D avid K. Stevenson is the Harold K. Faber Professor of Pediatrics and has m ade many impactful contributions to the field of neonatology and pediatric s\, including his seminal studies on neonatal jaundice\, bilirubin product ion and heme oxygenase biology. As a neonatologist\, his research has foc used primarily on neonatal jaundice and more recently on the causes of pre term birth and its prevention. He has held numerous leadership roles at S tanford University School of Medicine\, including Vice Dean and Senior Ass ociate Dean for Academic Affairs. He is currently the Senior Associate Dea n for Maternal & Child Health\, the Co-Director of the Stanford Maternal & Child Health Research Institute\, and the Principal Investigator for the March of Dimes Prematurity Research Center at Stanford University. Dr. St evenson has received many awards\, including the Virginia Apgar Award\, wh ich is the highest award in Perinatal Pediatrics\, the Joseph W. St. Geme\ , Jr. Leadership Award from the Federation of Pediatric Organizations\, th e Jonas Salk Award for Leadership in Prematurity Prevention from the March of Dimes Foundation\, and the John Howland Medal and Award\, the highest award in academic pediatrics. He has served as the President of the Ameri can Pediatric Society. In recognition of his achievements\, Dr. Stevenson is a member of the National Academy of Medicine.
ted by: Katherine Ferrara\, PhD
\nSponsored by: Molecular Im aging Program at Stanford & the Department of Radiology
Ticke ts: https://stanford.z oom.us/webinar/register/7116294064170/WN_H60DZOKZSlWC6UBOB3FTVw.DTSTART;TZID=America/Los_Angeles:20210923T120000 DTEND;TZID=America/Los_Angeles:20210923T124500 LOCATION:Zoom - See Description for Zoom Link SEQUENCE:0 SUMMARY:MIPS Seminar – David K. Stevenson\, MD URL:http://web.stanford.edu/group/radweb/cgi-bin/radcalendar/event/mips-sem inar-david-k-stevenson-md/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;http://web.stanford.edu/group/radweb/cgi-bin/rad calendar/wp-content/uploads/2019/10/david-stevenson_profilephoto-150x150.j pg\;150\;150\;1\,medium\;http://web.stanford.edu/group/radweb/cgi-bin/radc alendar/wp-content/uploads/2019/10/david-stevenson_profilephoto-300x300.jp g\;300\;300\;1\,large\;http://web.stanford.edu/group/radweb/cgi-bin/radcal endar/wp-content/uploads/2019/10/david-stevenson_profilephoto.jpg\;350\;35 0\; X-TICKETS-URL:https://stanford.zoom.us/webinar/register/7116294064170/WN_H6 0DZOKZSlWC6UBOB3FTVw END:VEVENT BEGIN:VEVENT UID:firstname.lastname@example.com/group/radweb/cgi-bin/radcalendar DTSTAMP:20231211T233930Z CATEGORIES;LANGUAGE=en-US:CME\,CME Radiology Grand Rounds\,Radiology CONTACT:Tricia Hatcliff\; 650-498-7359\; email@example.com DESCRIPTION:
CME Grand Rounds D iversity Lectureship – Topic: TBD\n
fer L. Eberhardt\, PhD
\n Stanford University
Join from PC\, Mac\, Linux\, iOS or
Android: https://stanford.zoom.us/j/600003703?pwd=RjcwS2MvOG1qVk
\nMeeting ID: 600 003 703
\nPassword: 566 048
\nOr iPhone one-tap (US Toll): +18333021536\,\,600003703# or +165 07249799\,\,600003703#
\nOr Telephone:
\nDial: +1 650 724 9799 ( US\, Canada\, Caribbean Toll) or +1 833 302 1536 (US\, Canada\, Caribbean Toll Free)
\nInternational numbers available: https://stanford.zoom.us/u/acuqphnvqT
\nComing soon!
\nComing soon!
CME Grand Rounds – "Community Based Partnered Research: Revisiting a Cri tical Concept for Radiology"\n
Christoph L. Lee\,
\nUniversity of Washington
Join from PC\, Mac\, Linux\, iOS or Andro
id: https://stanford.zoom.us/j/600003703?pwd=RjcwS2MvOG1qVkxyL3U
\nMeeting ID: 600 003 703
\nPassword: 566048\nOr iPhone one-tap (US Toll): +18333021536\,\,600003703# or +16507249 799\,\,600003703#
\nOr Telephone:
\nDial: +1 650 724 9799 (US\, Canada\, Caribbean Toll) or +1 833 302 1536 (US\, Canada\, Caribbean Toll Free)
\nInternational numbers available: https://stanford.zoom.us/u/acuqphnvqT
\nComing soon!
LOCATION:Zoom - See Description for Zoom Link
SUMMARY:CME Grand Rounds – Christoph L. Lee\, MD\, MS\, MBA
CATEGORIES;LANGUAGE=en-US:PHIND\,PHIND Seminar Series
CONTACT:Ashley Williams\; email@example.com
\nComing soon!
Christina Curtis\, Ph.D.
\nAssociate Professor of Medicine (Oncology) and of Genetics
\nStan ford University
Location: Venue coming soon!
\n11:0 0am – 12:00pm Seminar & Discussion
\n12:00pm – 12:15pm Reception
\nRSVP coming soon!
\nCo ming soon!
\nComing soon!
Hosted by: Garry Gold\, M.D.
\nSponsored by the PHIND Center and the Department of Radiology
CME Grand Rounds – Topic: TBD\n
Jocelyn D. Chertoff\, MD\, MS
\n Professor
\nRadiology\, Obstetrics & Gynecology
\nChair\, Radiol ogy
\nDartmouth Hitchcock Medical Center
Join from
PC\, Mac\, Linux\, iOS or Android: https://stanford.zoom.us/j/60
\nMeeting ID: 600 00 3 703
\nPassword: 566048
\nOr iPhone one-tap (US Toll): +1833302 1536\,\,600003703# or +16507249799\,\,600003703#
\nOr Telephone:
\nDial: +1 650 724 9799 (US\, Canada\, Caribbean Toll) or +1 833 302 1536 (US\, Canada\, Caribbean Toll Free)
\nInternational numbers availabl e: https://stanford.zoom.u s/u/acuqphnvqT
\nComi ng soon!
\nComing soon!
Steven Paul Poplack\, MD
\nProfessor of Radiology (Breast Imaging)
\nStanford University Med ical Center
Location: Coming soon!\n
12:00pm – 12:
45pm Seminar & Discussion
\nRSVP: Coming soon!
Coming soon!\n
\nComing soon!
Hosted by: Katherine F
errara\, PhD
\nSponsored by: Molecular Imaging Program at St anford & the Department of Radiology
CME Grand Rounds Etta K. Moskowitz Lectureship – Topic: TBD\n
Elizabeth Krupi
nski\, PhD
\nProfessor & Vice Chair for Research
\nRadi ology & Imaging Sciences
\nEmory University School of Medicine
Join from PC\, Mac\, Linux\, iOS or Android: https:/
\nMeeting ID: 600 003 703
\nPassword: 566048
\nOr iPhone one-t ap (US Toll): +18333021536\,\,600003703# or +16507249799\,\,600003703#
\nOr Telephone:
\nDial: +1 650 724 9799 (US\, Canada\, Caribbean To ll) or +1 833 302 1536 (US\, Canada\, Caribbean Toll Free)
\nInternat ional numbers available: h ttps://stanford.zoom.us/u/acuqphnvqT
\nComing soon!
\nComing soon!
CME Grand Rounds – "Promote Your Academic Career Using Social Me dia"\n
Michael Gisondi\, MD
\nAssociate Profes sor & Vice Chair of Education
\nEmergency Medicine
\nStanford Un iversity
Join from PC\, Mac\, Linux\, iOS or Android: https://stanford.zoom.us/j/600003703?pwd=RjcwS2MvOG1qVkxyL3U0RmNtU
\nMeeting ID: 600 003 703
\nPassword: 566048
\n Or iPhone one-tap (US Toll): +18333021536\,\,600003703# or +16507249799\,\ ,600003703#
\nOr Telephone:
\nDial: +1 650 724 9799 (US\, Canada \, Caribbean Toll) or +1 833 302 1536 (US\, Canada\, Caribbean Toll Free)< br />\nInternational numbers available: https://stanford.zoom.us/u/acuqphnvqT
\nComing soon!
\nComing soon!
PHIND Seminar Series: Male Infertility and the Future Risk of Vascul ar and CV Disease\n
Michael Eisenberg\, M.D.
\nAssociate P rofessor of Urology and\, by courtesy\, of Obstetrics and Gynecology
\nStanford University Medical Center
Gary M. Shaw\, Ph.D.\nNICU Nurses Professor and Professor\, by courtesy\, of Health Resear
ch and Policy (Epidemiology) and of Obstetrics and Gynecology (Maternal Fe
tal Medicine)
\nStanford University
Location: Venue
coming soon!
\n11:00am – 12:00pm Seminar & Discussion
\n12:00pm – 12:15pm Reception
\nRSVP coming soon!
\nComing soon!
\nComing soon!
Hosted by: Garry Gold\, M.D.<
\nSponsored by the PHIND Center and the Department of Radiol ogy
MIPS Seminar Series: Title TBA\n
Matthew Bogyo\, PhD
\nProf essor of Pathology and of Microbiology and Immunology and\, by courtesy\, of Chemical and Systems Biology
\nStanford University
Location: Coming soon!\n
12:00pm – 12:45pm Seminar & Discussion\nRSVP: Coming soon!\n
Coming soon!\n
\nDr. Bogyo received a B.Sc. degree in Chemistry from Bates College in 1993 and a Ph.D . in Biochemistry from the Massachusetts Institute of Technology in 1997. After completion of his degree he was appointed as a Faculty Fellow in the Department of Biochemistry and Biophysics at the University of California \, San Francisco. Dr. Bogyo served as the Head of Chemical Proteomics at C elera Genomics from 2001 to 2003 while maintaining an Adjunct Faculty appo intment at UCSF. In the Summer of 2003 Dr. Bogyo joined the Department of Pathology at Stanford Medical School and was appointed as a faculty member in the Department of Microbiology and Immunology in 2004. His interests a re focused on the use of chemistry to study the role of proteases in human disease. In particular his laboratory is currently working on understandi ng the role of cysteine proteases in tumorgenesis and also in the life cyc le of human parasites and bacterial pathogens. Dr. Bogyo currently serves on the Editorial Board of Biochemical Journal\, Cell Chemical Biology\, Mo lecular and Cellular Proteomics and is an Academic Editor at PLoS One. Dr. Bogyo is a consultant for several biotechnology and pharmaceutical compan ies in the Bay Area and is a founder and board member of Akrotome Imaging and Facile Therapeutics.
Hosted by: Katherine Ferrar
a\, PhD
\nSponsored by: Molecular Imaging Program at Stanfor d & the Department of Radiology